Ifedayo Adetifa

Dados Biográficos

ID7039442
NOMEIfedayo Adetifa
PRENOMESIfedayo
SOBRENOMEAdetifa
ASSINATURAADETIFA I
AFILIAÇÕESKenya Medical Research Institute
ORCID0000-0003-2556-9407
VERIFICADOSim
TOTAL DE OBRAS15
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR15
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2017
ANO MAIS RECENTE DE PUBLICAÇÃO2026
ÍNDICE H0

  • Trends and patterns of varicella zoster virus infection in Kilifi

    Open AccessAntipa Sigilai, Antipa Kirwa Sigilai et al.ARTICLEPLOS Global Public Health2026

    There is limited epidemiologic data on varicella zoster virus (VZV) infections from low- and middle-income countries including Kenya. We aimed to describe the seroepidemiology of VZV in Kilifi, Kenya, where varicella vaccine is not included in the national infant immunization program, in order to generate evidence to inform vaccine policy. We conducted a retrospective serosurvey utilizing archived plasma and serum samples from cross-sectional pop…

  • Prevalence, spatial and temporal distribution of tungiasis in the Kilifi Health and Demographic Surveillance System (KHDSS) in Kenya

    Open AccessNelson Ouma, Samuel K Muchiri et al.ARTICLEBMJ Global Health2026

    INTRODUCTION: Tungiasis is a highly neglected tropical disease of the skin caused by an embedded female sand flea affecting the most resource-poor communities in sub-Saharan Africa, the Caribbean and South America. The global disease burden is unknown and systematic, fine-resolution spatial data on prevalence and environmental and ecological risk factors are rare. METHODS: We leveraged the Kilifi Health and Demographic Surveillance System of 90 2…

  • Unlocking potential

    Open AccessSharonann Lynch, Ifedayo Adetifa et al.ARTICLEPLOS Global Public Health2026

  • Asean’s response to mpox

    Open AccessAfifah Rahman-Shepherd, Ahmed Razavi et al.ARTICLEPLOS Global Public Health2025

  • Tobacco smoking clusters in households affected by tuberculosis in an individual participant data meta-analysis of national tuberculosis prevalence surveys

    Open AccessYohhei Hamada, Matteo Quartagno et al.ARTICLEPLOS Global Public Health2024

    Tuberculosis (TB) and non-communicable diseases (NCD) share predisposing risk factors. TB-associated NCD might cluster within households affected with TB requiring shared prevention and care strategies. We conducted an individual participant data meta-analysis of national TB prevalence surveys to determine whether NCD cluster in members of households with TB. We identified eligible surveys that reported at least one NCD or NCD risk factor through…

  • Performance evaluation of Sars-CoV-2 rapid diagnostic tests in Nigeria

    Open AccessAkhere A Omonkhua, Adedayo Omotayo FANEYE et al.ARTICLEPLOS Global Public Health2024

    The COVID-19 pandemic challenged health systems globally. Reverse transcription polymerase chain reaction (RT-PCR) is the gold standard for detecting the presence of SARS-CoV-2 in clinical samples. Rapid diagnostic test (RDT) kits for COVID-19 have been widely used in Nigeria. This has greatly improved test turnover rates and significantly decreased the high technical demands of RT-PCR. However, there is currently no nationally representative eva…

  • Mpox (monkeypox) risk and mortality associated with HIV infection

    Open AccessAdesola Yinka-Ogunleye, Mahmood Dalhat et al.ARTICLEBMJ Global Health2023

    INTRODUCTION: Recent outbreaks of mpox are characterised by changes in the natural history of the disease, the demographic and clinical characteristics of the cases, and widening geographical distribution. We investigated the role of HIV and other sexually transmitted infections (STIs) coinfection among cases in the re-emergence of mpox to inform national and global response. METHODS: We conducted a national descriptive and case-control study on …

  • The Lancet Nigeria Commission

    Open AccessIbrahim Abubakar, Sarah L Dalglish et al.ARTICLEThe Lancet2022

    Health is central to the development of any country. Nigeria’s gross domestic product is the largest in Africa, but its per capita income of about ₦770 000 (US$2000) is low with a highly inequitable distribution of income, wealth, and therefore, health. It is a picture of poverty amidst plenty. Nigeria is both a wealthy country and a very poor one. About 40% of Nigerians live in poverty, in social conditions that create ill health, and with the e…

  • The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria

    Open AccessAishatu L Adamu, Boniface Karia et al.ARTICLEBMJ Global Health2022

    BACKGROUND: Pneumococcal disease contributes significantly to childhood morbidity and mortality and treatment is costly. Nigeria recently introduced the pneumococcal conjugate vaccine (PCV) to prevent pneumococcal disease. The aim of this study is to estimate health provider and household costs for the treatment of pneumococcal disease in children aged <5 years (U5s), and to assess the impact of these costs on household income. METHODS: We recrui…

  • Sars-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021

    Open AccessAnthony Etyang, Ifedayo Adetifa et al.ARTICLEPLOS Global Public Health2022

    Background Most of the studies that have informed the public health response to the COVID-19 pandemic in Kenya have relied on samples that are not representative of the general population. We conducted population-based serosurveys at three Health and Demographic Surveillance Systems (HDSSs) to determine the cumulative incidence of infection with SARS-CoV-2. Methods We selected random age-stratified population-based samples at HDSSs in Kisumu, Nai…

  • Telling our own story in global health–experience from Nigeria

    Open AccessChikwe Ihekweazu, Ifedayo Adetifa et al.ARTICLEPLOS Global Public Health2022

  • Covid-19 vaccine effectiveness studies in Nigeria

    Open AccessOluwatosin Wuraola Akande, Oluwatosin Akande et al.ARTICLEJournal of Global Health2022

    The “lickety–split” development of COVID-19 vaccines 326 days from when the SARS-COV-2 virus was first sequenced is indeed one of the public health successes of the 21st century. Particularly because an 18-month target was initially considered reasonable, and having achieved this success, a “moonshot” goal to ensure that a vaccine is available within 100 days [...]

  • Knowledge, attitude and practice towards tuberculosis in Gambia

    Open AccessAdedapo Olufemi Bashorun, Christopher Linda et al.ARTICLEBMC Public Health2020

    About 3 in 10 Gambians had poor knowledge on TB, and significant stigma towards TB and persons with TB persists. Interventions to improve TB knowledge and address stigma are required as part of efforts to reduce the burden of undiagnosed TB in the country

  • Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016

    Open AccessChristopher Troeger, Brigette F Blacker et al.ARTICLEThe Lancet Infectious Diseases2018

    BACKGROUND: Lower respiratory infections are a leading cause of morbidity and mortality around the world. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study 2016, provides an up-to-date analysis of the burden of lower respiratory infections in 195 countries. This study assesses cases, deaths, and aetiologies spanning the past 26 years and shows how the burden of lower respiratory infection has changed in people of all ages. MET…

  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016

    Open AccessHaidong Wang, Amanuel Alemu Abajobir et al.ARTICLEThe Lancet2017

    BACKGROUND: Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause mortality has changed with respect to development status can identify exemplars for best practice. To accomplish this, the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) estimated age-specific and …